Researchers awarded grant to develop genetic risk score for thyroid cancer
Researchers at the University of Colorado School of Medicine, USA, are hopeful new research could…
Browsing: thyroid cancer
Genetic alterations in thyroid cancer mediate resistance to BRAF inhibition and anaplastic transformation
A new research perspective was published in Oncotarget’s Volume 15 on January 24, 2024, entitled, “Genetic alterations in…
Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy
A newly developed PET imaging agent has been found to be effective in identifying medullary…
The role of fibronectin in BRAF-mutant thyroid cancer treatment
New research overseen by University of Colorado Cancer Center (USA) member Rebecca Schweppe, PhD, could…
PFAS linked to thyroid cancer risk in humans
Some per- and polyfluoroalkyl substances (PFAS) – also known as “forever chemicals” – may be…
Pretherapy imaging and dosimetry offer personalised treatment planning for thyroid cancer patients
A combination of pretherapy imaging and dosimetry can help ensure that patients with refractory differentiated…
NCCN launches roadmap for improving thyroid cancer care in LMICs
The National Comprehensive Cancer Network (NCCN) is introducing a new global resource to improve thyroid…
ASCO 2023: Thyroid cancer precision approaches that incorporate targeted therapies and other treatments are changing the surgeon’s role
Historically, surgery was the first line of treatment for patients with thyroid cancer. Now, as…
French nuclear testing in Pacific slightly raised cancer rates in Polynesia
Residents of French Polynesia have higher rates of thyroid cancer than would have occurred without…
Genomic screening can help detect thyroid cancer
Population-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with…